InvestorsHub Logo
Followers 87
Posts 6641
Boards Moderated 1
Alias Born 09/18/2009

Re: eb0783 post# 42008

Wednesday, 02/28/2024 5:33:29 PM

Wednesday, February 28, 2024 5:33:29 PM

Post# of 42746
You're right, eb.

And there's so much going on. Today, for example, Baudax filed a CH11. Will this give us the opportunity to bid on Tera-Immune?

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1780097/000119312524049000/d800225d8k.htm

And Sanofi's notice of appointing 3 Independent Directors yesterday, having already announced plans to spin-off their healthcare business, suggests preparations to ready the spin-off for Nasdaq listing.

https://www.sec.gov/Archives/edgar/data/1121404/000119312524047460/d702412dex993.htm

And as Preciouslife1's article informed us today, "Novavax expects full-year 2024 revenue to come in between $800 million and $1 billion. That forecast reflects an expected $500 million to $600 million in revenue from advanced purchase agreements and $300 million to $400 million from commercial market product sales, royalties and other revenue from the company’s “partner-related activity.”

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173936647